Yujiro Aoki

Yujiro Aoki

Auto-generated profile, based on publicly available information

Yujiro Aoki

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in International Journal of Urology
Verified
Journal Article
Closed access
KSKazunobu Shinoda
Kazunobu Shinoda
YHYoji Hyodo
Yoji Hyodo
HOHideyo Oguchi
Hideyo Oguchi
TMTetuo Mikami
Tetuo Mikami
KNKenta Nishikawa
Kenta Nishikawa
SSSeiichiro Shishido
Seiichiro Shishido

11 December 2019 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
YAYujiro Aoki
Yujiro Aoki
YHYuko Hamasaki
Yuko Hamasaki
HSHiroyuki Satoh
Hiroyuki Satoh
ZMZenichi Matsui
Zenichi Matsui
MMMasaki Muramatsu
Masaki Muramatsu
SSSeiichiro Shishido
Seiichiro Shishido

5 December 2022 in Pediatric Transplantation
Verified
Journal Article
Closed access
MKMai Kubota
Mai Kubota
YHYuko Hamasaki
Yuko Hamasaki
JHJunya Hashimoto
Junya Hashimoto
YAYujiro Aoki
Yujiro Aoki
TKTakeshi Kawamura
Takeshi Kawamura
KSKen Sakai
Ken Sakai

1 August 2021 in Journal of Pediatric Urology
Verified
Journal Article
Open access
YAYujiro Aoki
Yujiro Aoki
HSHiroyuki Satoh
Hiroyuki Satoh
ASAtsuko Sato
Atsuko Sato
YMYosuke Morizawa
Yosuke Morizawa
RHRiku Hamada
Riku Hamada
KSKen Sakai
Ken Sakai
Kidney transplantation (KTx) is the most effective treatment for end-stage renal disease in children. We aimed to compare the long-term outcomes and surgical complications of the intraperitoneal approach (IPA) and extraperitoneal approach (EPA) for KTx in children weighing <15 kg. We performed a retrospective cohort study on pediatric kidney transplant recipients, weighing <15 kg, who received their first living-related kidney transplant between January 1987 and December 2015. Patients were divided into two groups based on the surgical approach (IPA or EPA) during transplant, and clinical data were extracted from the medical records. The median follow-up duration was 14.1 years (interquartile range, 9.0-19.2). Comparing the two groups (IPA group, n = 62; EPA group, n = 38), the median age and body weight were significantly lower in the IPA group (4.2 vs. 4.8 years, P = 0.03; 11.7 vs. 13.0 kg, P < 0.01). There were 26 surgical complications (26%) in 19 patients during the follow-up period. The surgical complication rate was higher in the IPA group (39% vs. 6%). We assessed the long-term outcomes of the surgical approaches used for pediatric patients weighing <15 kg who underwent KTx and received a size-mismatched adult donor kidney. There was no significant difference in renal transplantation prognosis using the surgical approach, but IPA-related complications were more frequent in the long term. Therefore, our data suggest that in cases of donor-recipient size mismatch in pediatric KTx, the EPA, associated with fewer surgical complications, is preferable to the IPA if the patient's body size has sufficient space for allograft placement. The transplant approach did not influence the long-term outcomes in children weighing <15 kg, but EPA had fewer surgical complications and was technically safe.

27 September 2021 in Clinical and Experimental Nephrology
Verified
Journal Article
Open access
PDF file
YAYujiro Aoki
Yujiro Aoki
HSHiroyuki Satoh
Hiroyuki Satoh
YHYuko Hamasaki
Yuko Hamasaki
RHRiku Hamada
Riku Hamada
RHRyoko Harada
Ryoko Harada
KSKen Sakai
Ken Sakai
Background: Malignancy after kidney transplantation (KT) is one of the most serious post-transplant complications. This study aimed to investigate the incidence, type, and outcomes of malignancy after pediatric KT. Methods: We performed a retrospective cohort study on pediatric kidney transplant recipients aged 18 years or younger who received their first transplant between 1975 and 2009. Results: Among the 375 children who underwent KT, 212 were male (56.5%) and 163 were female (43.5%) (median age at KT, 9.6 years [interquartile range {IQR}] 5.8–12.9 years). The incidence of malignancy was 5.6% (n = 21). The cumulative incidences of cancer were 0.8%, 2.5%, 2.8%, 4.2%, 5.5%, and 15.6% at 1, 5, 10, 15, 20, and 30 years post-transplantation, respectively. Of 375 patients, 12 (3.2%) had solid cancer and nine (2.4%) had lymphoproliferative malignancy. The median age at the first malignancy was 21.3 years (IQR 11.5–33.3 years). The median times from transplant to diagnosis were 22.3 years (IQR 12.3–26.6 years) for solid cancer and 2.2 years (IQR 0.6–2.8) for lymphoproliferative malignancies. During follow-up, five recipients died due to malignancy. The causes of death were hepatocellular carcinoma in one patient, squamous cell carcinoma in the transplanted kidney in one patient, malignant schwannoma in one patient, and Epstein-Barr virus-related lymphoma in two patients. The mortality rate was 0.79 per 1000 person-years (95% confidence interval 0.38, 1.85). Conclusions: Early diagnosis and treatment of malignancies in transplant recipients is an important challenge. Therefore, enhanced surveillance and continued vigilance for malignancy following KT are necessary.

1 August 2020 in Transplant International
Verified
Journal Article
Closed access
PDF file
MMMasaki Muramatsu
Masaki Muramatsu
YHYuko Hamasaki
Yuko Hamasaki
TMToshihide Mizutani
Toshihide Mizutani
YTYusuke Takahashi
Yusuke Takahashi
JHJunya Hashimoto
Junya Hashimoto
SSSeiichiro Shishido
Seiichiro Shishido
Renal transplantation of adult-size kidneys presents a size mismatch in small children. This study presents a comparison of live donor predonation and recipient post-transplant kidney volumes (k-vol) and glomerular size at 1 year after transplantation. We analyzed 47 pediatric renal transplant recipients weighing <15 kg between 2009 and 2017. The k-vol before and 1 year after transplantation and glomerular size at implant and 1 year post-transplant were evaluated. We estimated the relationships between these changes and graft function, and the factors associated with k-vol. Pretransplant k-vol was 158.1 +/- 25.1 ml, and the k-vol at 1 year post-transplant was significantly reduced by -17.2% to 132.3 +/- 27.3 ml (P < 0.001). Implant glomerular size showed the diameter was 165.3 +/- 15.1 mu m and the area 20 737.1 +/- 3230.6 mu m(2). One-year post-transplant, the glomerular diameter was 150.6 +/- 11.4 mu m and the area 17 428.3 +/- 2577.9 mu m(2), significantly reduced compared with implantation values (bothP < 0.001). The change in k-vol was affected by pretransplant abdominal cavity (ml/200 ml cavity volume, partial regression coefficient = 0.029, SE = 0.009,P = 0.004) and recipient's weight gain (ml/5% of weight gain, partial regression coefficient = 0.020, SE = 0.006,P = 0.002). In small pediatric transplants, an adult-size kidney is acceptable with reduction in k-vol. Moreover, the post-transplant k-vol might be regulated by pretransplant physique and post-transplant somatic growth.